These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5602966)

  • 1. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
    Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 5. [Utilization in the treatment of tuberculosis in children of a single daily oral dose of isoniazid and para-aminosalicylic acid].
    Sarrouy C; Viallier J; Vaillaud JC
    Ann Pediatr (Paris); 1967 Mar; 14(3):219-24. PubMed ID: 5614546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the use of ethambutol in venous perfusion associated with perfusions of PAS and INI in the treatment of pulmonary tuberculosis].
    Fossati C
    G Ital Mal Torace; 1971; 25(1):31-6. PubMed ID: 5131786
    [No Abstract]   [Full Text] [Related]  

  • 8. Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid.
    Yue WY; Cohen SS
    Dis Chest; 1966 Feb; 49(2):165-74. PubMed ID: 5907972
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of antibacterial therapy of tuberculosis using the intermittent and continuous methods].
    Belinskiĭ AN
    Vrach Delo; 1966 Aug; 8():105-6. PubMed ID: 5989120
    [No Abstract]   [Full Text] [Related]  

  • 10. [New drugs in the treatment of primary tuberculosis].
    Gerbeaux J; Hanoteau J
    Ann Pediatr (Paris); 1970 Oct; 17(10):638-43. PubMed ID: 5475417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative findings from various approaches of treating infiltrative and cavernous pulmonary tuberculosis in rabbits].
    Bondarev IM; Klebanova AA; Novoselova VP
    Probl Tuberk; 1971; 49(3):47-52. PubMed ID: 5562450
    [No Abstract]   [Full Text] [Related]  

  • 12. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of renal tuberculosis.
    Beck AD
    Aust N Z J Surg; 1969 May; 38(4):342-6. PubMed ID: 4977937
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our region's possibilities in the ambulatory treatment of pulmonary tuberculosis with the biweekly administration of a perfused triple combination of isoniazid, streptomycin and PAS].
    Burghard G; Petitjean R; Scherrer B; Schranz J
    Rev Tuberc Pneumol (Paris); 1970; 34(5):662-3. PubMed ID: 5496786
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous injection of isoniazid and PAS twice weekly to outpatients with tuberculosis in rural areas].
    Ursov IG; Volokitin FN; Borovinskaia TA
    Probl Tuberk; 1983 Nov; (11):42-5. PubMed ID: 6675002
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of tuberculosis.
    Mathur AK
    N Engl J Med; 1971 Aug; 285(7):410-1. PubMed ID: 4104145
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacogenetic and interaction-model with some usual antitubercular agents].
    Hanngren A; Boman G; Borgå O; Malmborg AS; Sjöqvist F
    Nord Med; 1970 Sep; 84(38):1204. PubMed ID: 5469274
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of ethambutol as a supplement to standard triple-drug regimen.
    Sunahara S
    Bull Int Union Tuberc; 1970 Jun; 43():316-21. PubMed ID: 5425561
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood concentration of basic tuberculostatic preparations with single administration of daily doses in pulmonary tuberculosis].
    Kanevskaia SS
    Probl Tuberk; 1970; 48(10):54-8. PubMed ID: 5496751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of sodium para-aminosalicylate on the concentration of isoniazid (tubazid) in the blood of patients with tuberculosis].
    Kozulitsina TI; Korotaev GA
    Ter Arkh; 1969; 41(10):94-7. PubMed ID: 5359356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.